Ruthenium‐Catalyzed para‐Selective C−H Alkylation of Aniline Derivatives
- 24 October 2017
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 56 (47) , 15131-15135
Abstract
The para‐selective C−H alkylation of aniline derivatives furnished with a pyrimidine auxiliary is herein reported. This reaction is proposed to take place via an N−H‐activated cyclometalate formed in situ. Experimental and DFT mechanistic studies elucidate a dual role of the ruthenium catalyst. Here the ruthenium catalyst can undergo cyclometalation by N−H metalation (as opposed to C−H metalation in meta‐selective processes) and form a redox active ruthenium species, to enable site‐selective radical addition at the para position.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/G03768X/1)
This publication has 79 references indexed in Scilit:
- Weak Coordination as a Powerful Means for Developing Broadly Useful C–H Functionalization ReactionsAccounts of Chemical Research, 2011
- Pd(II)-Catalyzed para-Selective C–H Arylation of Monosubstituted ArenesJournal of the American Chemical Society, 2011
- Carboxylate-Assisted Transition-Metal-Catalyzed C−H Bond Functionalizations: Mechanism and ScopeChemical Reviews, 2011
- A Highly Para‐Selective Copper(II)‐Catalyzed Direct Arylation of Aniline and Phenol DerivativesAngewandte Chemie, 2010
- Palladium-Catalyzed Ligand-Directed C−H Functionalization ReactionsChemical Reviews, 2010
- Palladium(II)‐Catalyzed C-H Activation/C-C Cross‐Coupling Reactions: Versatility and PracticalityAngewandte Chemie International Edition, 2009
- Pd(II)-Catalyzed Olefination of Electron-Deficient Arenes Using 2,6-Dialkylpyridine LigandsJournal of the American Chemical Society, 2009
- Room‐Temperature Palladium‐Catalyzed C-H Activation: ortho‐Carbonylation of Aniline DerivativesAngewandte Chemie International Edition, 2009
- Room‐Temperature Palladium‐Catalyzed C-H Activation: ortho‐Carbonylation of Aniline DerivativesAngewandte Chemie, 2009
- AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLBritish Journal of Cancer, 2006